Article
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies
2023-04-11
Abstract excerpt
Chimeric antigen receptor (CAR) T cell therapy has emerged as a new opportunity for cancer treatment; however, resistance can occur due to intrinsic (T cells), extrinsic (tumors), or acquired (tumors) factors. In many cases, the knowledge of these mechanisms comes from clinical observations of patients treated with CAR T cells. In addition, the structure of the CAR molecule and the manufacturing process can impact...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2dac89dc-6f0d-5d9b-a03a-129c9526a8b1
- DOI
- 10.1146/annurev-cancerbio-061421-012235
